Advertisement
JJB has signed three new Southern Region exclusive, one-year renewableDistribution and Agency Agreements that were signed with Changsha Hongli Co.,Ltd. ("CHC"), Wenzhou Limeikang Trade., Ltd. ("WLT") and Xiamen Larry BeautyTechnology Co., Ltd. ("XLB"). These agreements cover the key cities in Hunnan,Zhejiang and Fujian Provinces that have a combined population of approximately134.4 million people. These two separate agreements in combination, requirethese new distributors to purchase a minimum of US$7,126,496 of JJB's newGoodnak product during the one-year period of the contracts and a minimuminitial order of US$3,563,248.
Advertisement
Frank Zheng, managing director of JPI, said these additional distributionagreement puts the Company on the path to building sales of Goodnak by as muchas $24 million over the next 12 months. These agreements, couple with thepreviously announced agreements, provide JJB with a current total ofapproximately $10.47 million in anticipated orders for its new Goodnakproduct. Gary Dreher, CEO of AMDL said the Company expects to further updatethe market on our expansion plans in the coming weeks.
About Goodnak: Goodnak is a high quality injectable anti-aging & skin careproduct that contains an amalgam of various therapeutic elements includinghuman placental histosolution ("HPH"). JPI began selling Goodnak, in August,through wholesale distribution channels that service high-end beauty salon andplastic surgery hospitals and medical cosmetology institutions. Goodnakproduct information is available on Jade Pharma's product specific website:www.jade-amdl.com.
About JPI: Jade Pharmaceutical through its subsidiaries JJB & YYB hasaccess to the fastest growing pharmaceutical and consumer market in the world:China. AMDL, through its subsidiary, Jade currently manufactures large volumeinjectable fluids, tablets and other related products, holding licenses for133 products. It also manufactures 107 generic, over the counter andsupplemental pharmaceutical products under certified Chinese GoodManufacturing Practice (CGMP) standards.
About AMDL: More information about AMDL and its products can be obtainedat www.amdl.com.
Forward-Looking Statements: This news release contains forward-lookingstatements within the meaning of the Private Securities Litigation Reform Actof 1995. Such statements are subject to certain risks and uncertainties, andactual circumstances, events or results may differ materially from thoseprojected in such forward-looking statements. The Company cautions readers notto place undue reliance on any forward-looking statements. The Company doesnot undertake, and specifically disclaims any obligation, to update or revisesuch statements to reflect new circumstances or unanticipated events as theyoccur.Contact: AMDL, Inc. Mr. Paul Knopick AMDL Investor Relations Direct Line: 949.707.5365 VoiceMail: 714.505.4460
SOURCE AMDL
